A digital approach to building better peptides
Solid-phase peptide synthesis is a well established process that’s used to manufacture peptides for both clinical development and commercial supply. Currently available technologies, however, are prone to errors and may not provide all the answers that modern formulators need. Dr Kevin Robinson (KSR) recently caught up with Almac’s Steve McIntyre (SM), Manager, Peptide Process Development, to discuss a novel solution that takes a digitalisation approach to overcoming these hurdles.
View Resource
Almac API, Chemical Development, Analytical & Solid State Services
Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).
We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.
We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.
Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.